STADA directly supplies MOVAPO®,Ropivacaine ReadyfusOR and PropofusOR in Australia.

At STADA Australia, we launched our specialty products, focused on the treatment of Parkinson’s disease, in Australia and New Zealand in 2016 and in August 2017, we expanded our portfolio to include Pain Management.

We work closely with Britannia Pharmaceuticals and BioQ Pharma to bring innovative therapies and the latest advancements to Australia and New Zealand.
 

Research and development

We invest in research and development to deliver innovative therapies that address the unmet needs of patients and their carers.

Contact us

For all enquiries, please phone 1800 791 660 or email medinfo(at)stada.com.au